table of content
1 Study Coverage
1.1 Viral Molecular Diagnostics Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million) Introduction
1.2 Global Viral Molecular Diagnostics Outlook 2017 VS 2022 VS 2028
1.2.1 Global Viral Molecular Diagnostics Market Size for the Year 2017-2028
1.2.2 Global Viral Molecular Diagnostics Market Size for the Year 2017-2028
1.3 Viral Molecular Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Viral Molecular Diagnostics in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Viral Molecular Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Viral Molecular Diagnostics Market Dynamics
1.4.1 Viral Molecular Diagnostics Industry Trends
1.4.2 Viral Molecular Diagnostics Market Drivers
1.4.3 Viral Molecular Diagnostics Market Challenges
1.4.4 Viral Molecular Diagnostics Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Viral Molecular Diagnostics by Type
2.1 Viral Molecular Diagnostics Market Segment by Type
2.1.1 Hepatitis B Virus (HBV)
2.1.2 Hepatitis C Virus (HCV)
2.1.3 Human Immunodeficiency Virus (HIV)
2.1.4 Human Papillomavirus (HPV)
2.2 Global Viral Molecular Diagnostics Market Size by Type (2017, 2022 & 2028)
2.3 Global Viral Molecular Diagnostics Market Size by Type (2017-2028)
2.4 United States Viral Molecular Diagnostics Market Size by Type (2017, 2022 & 2028)
2.5 United States Viral Molecular Diagnostics Market Size by Type (2017-2028)
3 Viral Molecular Diagnostics by Application
3.1 Viral Molecular Diagnostics Market Segment by Application
3.1.1 Hospitals
3.1.2 Academics Institutions
3.1.3 Laboratories
3.1.4 Others
3.2 Global Viral Molecular Diagnostics Market Size by Application (2017, 2022 & 2028)
3.3 Global Viral Molecular Diagnostics Market Size by Application (2017-2028)
3.4 United States Viral Molecular Diagnostics Market Size by Application (2017, 2022 & 2028)
3.5 United States Viral Molecular Diagnostics Market Size by Application (2017-2028)
4 Global Viral Molecular Diagnostics Competitor Landscape by Company
4.1 Global Viral Molecular Diagnostics Market Size by Company
4.1.1 Top Global Viral Molecular Diagnostics Companies Ranked by Revenue (2021)
4.1.2 Global Viral Molecular Diagnostics Revenue by Player (2017-2022)
4.2 Global Viral Molecular Diagnostics Concentration Ratio (CR)
4.2.1 Viral Molecular Diagnostics Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Viral Molecular Diagnostics in 2021
4.2.3 Global Viral Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Viral Molecular Diagnostics Headquarters, Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.1 Global Viral Molecular Diagnostics Headquarters and Area Served
4.3.2 Global Viral Molecular Diagnostics Companies Revenue in Viral Molecular Diagnostics Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Viral Molecular Diagnostics Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Viral Molecular Diagnostics Market Size by Company
4.5.1 Top Viral Molecular Diagnostics Players in United States, Ranked by Revenue (2021)
4.5.2 United States Viral Molecular Diagnostics Revenue by Players (2020, 2021 & 2022)
5 Global Viral Molecular Diagnostics Market Size by Region
5.1 Global Viral Molecular Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Viral Molecular Diagnostics Market Size by Region (2017-2028)
5.2.1 Global Viral Molecular Diagnostics Market Size by Region: 2017-2022
5.2.2 Global Viral Molecular Diagnostics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Viral Molecular Diagnostics Market Size YoY Growth 2017-2028
6.1.2 North America Viral Molecular Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Viral Molecular Diagnostics Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Viral Molecular Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Viral Molecular Diagnostics Market Size YoY Growth 2017-2028
6.3.2 Europe Viral Molecular Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Viral Molecular Diagnostics Market Size YoY Growth 2017-2028
6.4.2 Latin America Viral Molecular Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Viral Molecular Diagnostics Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Viral Molecular Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott Laboraories
7.1.1 Abbott Laboraories Company Details
7.1.2 Abbott Laboraories Business Overview
7.1.3 Abbott Laboraories Viral Molecular Diagnostics Introduction
7.1.4 Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.1.5 Abbott Laboraories Recent Development
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Company Details
7.2.2 Bio-Rad Laboratories Business Overview
7.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Introduction
7.2.4 Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.2.5 Bio-Rad Laboratories Recent Development
7.3 Becton, Dickinson
7.3.1 Becton, Dickinson Company Details
7.3.2 Becton, Dickinson Business Overview
7.3.3 Becton, Dickinson Viral Molecular Diagnostics Introduction
7.3.4 Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.3.5 Becton, Dickinson Recent Development
7.4 Roche
7.4.1 Roche Company Details
7.4.2 Roche Business Overview
7.4.3 Roche Viral Molecular Diagnostics Introduction
7.4.4 Roche Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.4.5 Roche Recent Development
7.5 Gen-Probe
7.5.1 Gen-Probe Company Details
7.5.2 Gen-Probe Business Overview
7.5.3 Gen-Probe Viral Molecular Diagnostics Introduction
7.5.4 Gen-Probe Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.5.5 Gen-Probe Recent Development
7.6 Qiagen
7.6.1 Qiagen Company Details
7.6.2 Qiagen Business Overview
7.6.3 Qiagen Viral Molecular Diagnostics Introduction
7.6.4 Qiagen Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.6.5 Qiagen Recent Development
7.7 Olympus
7.7.1 Olympus Company Details
7.7.2 Olympus Business Overview
7.7.3 Olympus Viral Molecular Diagnostics Introduction
7.7.4 Olympus Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.7.5 Olympus Recent Development
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Company Details
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Introduction
7.8.4 Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2017-2022)
7.8.5 Thermo Fisher Scientific Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
